Evaluation of MicroRNA-451a Expression in Lupus Nephritis
DOI:
https://doi.org/10.24293/ijcpml.v30i1.2070Keywords:
MicroRNA-451a expression, lupus, lupus nephritisAbstract
The pathogenesis of Lupus Nephritis (LN) is still unclear, causing difficulties in diagnosis and therapeutic management. Recent studies have suggested that microRNAs (miRNAs) may play an important role in the pathogenesis of LN. However, the role of miRNA-451a in LN has not been widely studied and known, and there is controversy in the results of studies that have been done. This study aimed to analyze the expression of miRNA-451a in LN and lupus without nephritis and to evaluate its correlation with hemoglobin levels, leukocyte count, leukocyturia, and erythrocyturia. Samples from 45 lupus participants were collected, consisting of 22 with LN and 23 without nephritis. The expression of microRNA 451a was determined by reverse transcriptase real-time PCR. Renal disorder criteria based on ACR criteria. Statistical analysis using Mann-Whitney, Spearman correlation, ROC curve, and table 2X2. MiRNA-451a expression in LN (median 0.31; range 0.06-7.21) was lower than in lupus without nephritis (median 1.31; range 0.07-13.26) with a significant difference (p=0.041). The cut-off value for comparing the two groups was 0.7531 with an accuracy of 75%. The correlation between miRNA 451a expression and hemoglobin levels, blood leukocyte count, erythrocyturia, and leukocyturia showed no significant correlation (p > 0.05). MicroRNA-451a expression in lupus nephritis was lower than in lupus without nephritis.
Downloads
References
Golder V, Hoi A. Systemic lupus erythematosus: An update. The Medical Journal of Australia, 2017; 206(5): 215-20.
Dörner T, Furie R. Novel paradigms in systemic lupus erythematosus. The Lancet, 2019; 393(10188): 2344-58.
Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. Journal of Autoimmunity, 2019; 96: 1-3.
Dörner T, Furie R. Novel paradigms in systemic lupus erythematosus. The Lancet, 2019; 393(10188): 2344-58.
Fulgeri C, Carpio JD, Ardiles L. Kidney injury in systemic lupus erythematosus: Lack of correlation between clinical and histological data. Nefrología (English Edition), 2018; 38(4): 380-7.
Cimbaluk D, Naumann A. Renal involvement in systemic lupus erythematosus: glomerular pathology, classification, and future directions. Diagnostic Histopathology, 2017; 23(3): 109-16.
Aringer M, Leuchten N, Johnson SR. New criteria for lupus. Current rheumatology reports. 2020 Jun;22:1-8.
Tselios K, Urowitz MB. Systemic lupus erythematosus. In: The heart in rheumatic, autoimmune, and inflammatory diseases. Philadelphia, Elsevier, 2017; 235–267.
Hong SM, Liu C, Yin Z, Wu L, Qu B, Shen N. MicroRNAs in systemic lupus erythematosus: A perspective on the path from biological discoveries to clinical practice. Current Rheumatology Reports, 2020; 22(6): 1-9.
Cheng J, Wu R, Long L, Su J, Liu J, et al. miRNA-451a targets IFN regulatory factor 8 for the progression of systemic lupus erythematosus. Inflammation, 2017; 40(2): 676-87.
Lu TX, Rothenberg ME. MicroRNA. Journal of Allergy and Clinical Immunology. 2018; 141(4): 1202-7.
O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in Endocrinology, 2018; 9: 402.
Wang T, Wu F, Yu D. MiR-144/451 in hematopoiesis and beyond. ExRNA, 2019; 1(1): 1-2.
Thomas D, Zachariah S, Elamin AE, Hashim AL. Limitations of serum creatinine as a marker of renal function. Sch Acad J Pharm, 2017; 6(5): 168-70.
Satoh M, Chan JY, Ceribelli A, Del-Mercado MV, Chan EK. Autoantibodies to argonaute 2 (Su antigen). Ten Years of Progress in GW/P Body Research, 2013; 45-59.
Tan L, Zhao M, Wu H, Zhang Y, Tong X, et al. Downregulated serum exosomal miR-451a expression correlates with renal damage and its intercellular communication role in systemic lupus erythematosus. Frontiers in Immunology, 2021; 12: 630112.
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update on the diagnosis and management of systematic lupus erythematosus. Annals of the Rheumatic Diseases, 2021; 80(1): 14-25.
Aringer M, Leuchten N, Johnson SR. New criteria for lupus. Current Rheumatology Reports, 2020; 22(6): 1-8.
Cai Z, Xie C, Qiao W, Fei X, Guo X, et al. The role of estrogen membrane receptor (g protein-coupled estrogen receptor 1) in skin inflammation induced by systemic lupus erythematosus serum IGg. Frontiers in Immunology, 2017; 8: 1723.
Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clinical Journal of the American Society of Nephrology, 2017; 12(5): 825-35.
Ng PC, Chan KY, Leung KT, Tam YH, Ma TP, et al. Comparative MiRNA expressional profiles and molecular networks in human small bowel tissues of necrotizing enterocolitis and spontaneous intestinal perforation. PLoS One, 2015; 10(8): e0135737.
Murata K, Yoshitomi H, Furu M, Ishikawa M, Shibuya H, Ito H, Matsuda S. MicroRNA 451 down regulates neutrophil chemotaxis via p38 MAPK. Arthritis and Rheumatology, 2014; 66(3): 549-59.
Cheng J, Wu R, Long L, Su J, Liu J, et al. MiRNA-451a targets IFN regulatory factor 8 for the progression of systemic lupus erythematosus. Inflammation, 2017; 40(2): 676-87.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
